Everett Harris & Co. CA Acquires 8,015 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Everett Harris & Co. CA increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 156,557 shares of the company's stock after buying an additional 8,015 shares during the period. Everett Harris & Co. CA owned about 0.13% of Henry Schein worth $10,834,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Cromwell Holdings LLC boosted its holdings in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after acquiring an additional 170 shares during the period. Versant Capital Management Inc raised its stake in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after buying an additional 335 shares during the last quarter. City State Bank acquired a new position in shares of Henry Schein during the 4th quarter worth approximately $55,000. Farther Finance Advisors LLC lifted its holdings in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after purchasing an additional 346 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock worth $109,000 after purchasing an additional 1,100 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Trading Up 0.9 %

HSIC stock traded up $0.72 during midday trading on Wednesday, reaching $81.30. The stock had a trading volume of 665,266 shares, compared to its average volume of 1,418,347. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $10.14 billion, a price-to-earnings ratio of 33.47, a PEG ratio of 2.21 and a beta of 0.91. The business has a fifty day simple moving average of $73.53 and a two-hundred day simple moving average of $71.60.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was up .4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.32 earnings per share. As a group, research analysts expect that Henry Schein, Inc. will post 4.76 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the topic of several research reports. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 target price for the company. Barrington Research boosted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a research report on Thursday, January 30th. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and an average target price of $80.10.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.